Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12931-020-01352-w http://scihub22266oqcxt.onion/10.1186/s12931-020-01352-w 32293449!7156898!32293449     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32293449&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32293449.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Respir+Res 2020 ; 21 (1): 83 Nephropedia Template TP {{tp|p=32293449|t=2020. Prognostic value of NT-proBNP in patients with severe COVID-19 |pdf=|usr=}}{{32293449}} gab.com Text Prognostic value of NT-proBNP in patients with severe COVID-19 JO: Respir Res http://www.kidney.de/pget.php?&tw=1&pmid=32293449 #FOAvip BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. The cardiac injury is a common condition among the hospitalized patients with COVID-19. However, whether N terminal pro B type natriuretic peptide (NT-proBNP) predicted outcome of severe COVID-19 patients was unknown. METHODS: The study initially enrolled 102 patients with severe COVID-19 from a continuous sample. After screening out the ineligible cases, 54 patients were analyzed in this study. The primary outcome was in-hospital death defined as the case fatality rate. Research information and following-up data were obtained from their medical records. RESULTS: The best cut-off value of NT-proBNP for predicting in-hospital death was 88.64 pg/mL with the sensitivity for 100% and the specificity for 66.67%. Patients with high NT-proBNP values (> 88.64 pg/mL) had a significantly increased risk of death during the days of following-up compared with those with low values (</=88.64 pg/mL). After adjustment for potential risk factors, NT-proBNP was independently correlated with in-hospital death. CONCLUSION: NT-proBNP might be an independent risk factor for in-hospital death in patients with severe COVID-19. TRIAL REGISTRATION: ClinicalTrials, NCT04292964. Registered 03 March 2020. Twit Text FOAVip Prognostic value of NT-proBNP in patients with severe COVID-19 ????Respir Res http://www.kidney.de/pget.php?&tw=1&pmid=32293449 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32293449 #FOAvip English Wikipedia <ref>{{Cite pmid|32293449}}</ref> Prognostic value of NT-proBNP in patients with severe COVID-19 #MMPMID32293449 Gao L; Jiang D; Wen XS; Cheng XC; Sun M; He B; You LN; Lei P; Tan XW; Qin S; Cai GQ; Zhang DY Respir Res 2020[Apr]; 21 (1): 83 PMID32293449show ga BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. The cardiac injury is a common condition among the hospitalized patients with COVID-19. However, whether N terminal pro B type natriuretic peptide (NT-proBNP) predicted outcome of severe COVID-19 patients was unknown. METHODS: The study initially enrolled 102 patients with severe COVID-19 from a continuous sample. After screening out the ineligible cases, 54 patients were analyzed in this study. The primary outcome was in-hospital death defined as the case fatality rate. Research information and following-up data were obtained from their medical records. RESULTS: The best cut-off value of NT-proBNP for predicting in-hospital death was 88.64 pg/mL with the sensitivity for 100% and the specificity for 66.67%. Patients with high NT-proBNP values (> 88.64 pg/mL) had a significantly increased risk of death during the days of following-up compared with those with low values ( |*Coronavirus Infections/diagnosis/mortality[MESH] |*Hospital Mortality[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/mortality[MESH] |Adult[MESH] |Aged[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Mortality[MESH] |Natriuretic Peptide, Brain/*analysis[MESH] |Peptide Fragments/*analysis[MESH] |Predictive Value of Tests[MESH] |Prognosis[MESH] |Reference Values[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]Prognostic value of NT-proBNP in patients with severe COVID-19 (epmc).pdf DeepDyve Pubget Overpricing